Literature DB >> 9570970

Treatment for fertility and risk of ovarian tumors of borderline malignancy.

F Parazzini1, E Negri, C La Vecchia, S Moroni, A Polatti, F Chiaffarino, M Surace, E Ricci.   

Abstract

The relationship between fertility drug use and risk of borderline ovarian cancer has been analyzed using data from a case-control study. Cases were 93 women aged 23 to 64 years with histologically confirmed diagnosis of borderline ovarian tumor (according to the World Health Organization criteria) who were admitted to the Obstetrics and Gynecology Clinics of the University of Milan. Control subjects were 273 women (ages 24-64 years) admitted for acute nongynecological, nonhormonal, and nonneoplastic conditions. Four cases (4.3%) and no control reported fertility drugs use: this difference was statistically significant (Fisher's exact test P = 0.004).

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9570970     DOI： 10.1006/gyno.1997.4928

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


  10 in total

1.  Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.

Authors:  Ivana Rizzuto; Renee F Behrens; Lesley A Smith
Journal:  Cochrane Database Syst Rev       Date:  2019-06-18

2.  Twenty-five-year-old Woman with Bilateral Borderline Ovarian Tumour Desiring to Preserve Fertility - Case Report and Literature Review on the Current State of Fertility Preservation in Women with Borderline Ovarian Tumours.

Authors:  S Findeklee; L Lotz; K Heusinger; I Hoffmann; R Dittrich; M W Beckmann
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-11       Impact factor: 2.915

3.  Multiple gestations: some public policy issues.

Authors:  P K Jennings; J C Callahan
Journal:  Health Care Anal       Date:  2001

4.  Fertility drugs and the risk of breast and gynecologic cancers.

Authors:  Louise A Brinton; Vikrant V Sahasrabuddhe; Bert Scoccia
Journal:  Semin Reprod Med       Date:  2012-04-27       Impact factor: 1.303

5.  In vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services.

Authors:  Louise A Brinton; Britton Trabert; Varda Shalev; Eitan Lunenfeld; Tal Sella; Gabriel Chodick
Journal:  Fertil Steril       Date:  2013-01-30       Impact factor: 7.329

6.  Long-term relationship of ovulation-stimulating drugs to breast cancer risk.

Authors:  Louise A Brinton; Bert Scoccia; Kamran S Moghissi; Carolyn L Westhoff; Shelley Niwa; David Ruggieri; Britton Trabert; Emmet J Lamb
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-04       Impact factor: 4.254

Review 7.  Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.

Authors:  Ivana Rizzuto; Renee F Behrens; Lesley A Smith
Journal:  Cochrane Database Syst Rev       Date:  2013-08-13

8.  Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort.

Authors:  F E van Leeuwen; H Klip; T M Mooij; A M G van de Swaluw; C B Lambalk; M Kortman; J S E Laven; C A M Jansen; F M Helmerhorst; B J Cohlen; W N P Willemsen; J M J Smeenk; A H M Simons; F van der Veen; J L H Evers; P A van Dop; N S Macklon; C W Burger
Journal:  Hum Reprod       Date:  2011-10-26       Impact factor: 6.918

9.  Borderline ovarian tumours in Vaud, Switzerland: incidence, survival and second neoplasms.

Authors:  F Levi; C La Vecchia; L Randimbison; V C Te
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

10.  Outcomes of controlled ovarian hyperstimulation/in vitro fertilization for infertile patients with borderline ovarian tumor after conservative treatment.

Authors:  Chan Woo Park; Kwang Moon Yang; Hye Ok Kim; Sung Ran Hong; Tae Jin Kim; Kyung Taek Lim; Ki Heon Lee; Inn Soo Kang
Journal:  J Korean Med Sci       Date:  2007-09       Impact factor: 2.153
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.